Advertisement

31P NMR Spectroscopy of Brain and Heart

  • L. Ligeti
  • C. Barlow
  • B. Chance
  • A. G. B. Kovach
  • M. O’Connor
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 159)

Abstract

It was in 1974 when Hoult first applied NMR techinque to measure metabolites containing phosphorous in rat muscle. Moon and Richards demonstrated that 31P NMR can be used to measure intracellular Ph. They were great steps forward in understanding the fine regulation of cellular energy metabolism in comparison to the classical biochemical techniques, since the method is nondestructive and it gives a continuous monitoring of phosphate metabolites. Using this method, the concentrations of ATP, phosphocreatine, sugar phosphate, and inorganic phosphates were monitored on frog gastrocnemius (Burt, Dawson, Gadian), isolated hearts and recently on all the perfusable organs under different conditions (Gadian, Nunnally, Cohen). The first in vivo 31P NMR experiment was carried out by Chance et al, who demonstrated the possibility of monitoring the levels of phosphorous containing metabolites of brain tissue in vivo. All these studies were done with relatively small bore magnets (1–3cm) limiting the extent of these experiments.

Keywords

Sugar Phosphate Carotid Artery Occlusion Helmholtz Coil Shed Blood Bilateral Carotid Artery Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Betz, E.: In: Blood Flow through Organs and Tissue, Livingston, Edinbourgh. 1968.Google Scholar
  2. 2.
    Burt, C. T., Glonek, T., Barany, M.: Biochemistry, N.Y. 15, 4850–4853, 1976.CrossRefGoogle Scholar
  3. 3.
    Busby, S. J. W., Gadian, D. G., Radda, G. K., Richards, R. E., Seeley, P. J.: Biochem. J. 170, 103–114, 1978.PubMedGoogle Scholar
  4. 4.
    Chance, B., Nakase, Y., Bond, M., Leigh, J. S., McDonald, G.: Proc. Natl. Acad. Sci. USA, 75, 4925–4929, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Cohen, S. M., Ogawa, S., Rottenberg, H., Glynn, P., Yamane, T., Brown, T. R., Shulman, R. G., Williamson, J. R.: Nature 273, 554–556, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Dawson, M. J., Gadian, D. G., Wilkie, D. R.: J. Physiol. 267, 703–735, 1977.PubMedGoogle Scholar
  7. 7.
    Dawson, M. J., Gadian, D. G., Wilkie, D. R.: Nature, Lond. 274, 861–866, 1978.CrossRefGoogle Scholar
  8. 8.
    Dawsonn, M. J., Gadian, D. G., Wilkie, D. R.:J. Physiol. 299, 465–484, 1980.Google Scholar
  9. 9.
    Dora, E., Kovach, A. G. B.: Acta Physiol. Adad, Sci. Hung. 54, 347–361, 1979.Google Scholar
  10. 10.
    Gadian, D. G., Hoult, D. I., Radda, G. K., Seeley, P. J., Chance, B., Barlow, C.: Prod. Natl. Acad. Sci. USA, 73, No. 12, 4446–4448, 1976.CrossRefGoogle Scholar
  11. 11.
    Harper, A. M.: J. Neural. Neurosurg, Psychiatr. 29, 398–403, 1966.CrossRefGoogle Scholar
  12. 12.
    Hoult, D. J., Busby, S. J. W., Gadian, D. G., Radda, G. K., Richards, R. E., Seeley, P. J.: Nature, Lond. 252, 285–287, 1974.CrossRefGoogle Scholar
  13. 13.
    Kovach, A. G. B., Dora, E.: Adv. Physiol. Sci. 25, 145–154.Google Scholar
  14. 14.
    Nunnally, P. A., Bottanley, P. A.: Science, 211, 177–180, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Siesjo, B. K., Nilsson, L., Rokeach, M., Zwetenow, N. N.: Brain Hypoxia, London 79–92, 1971.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • L. Ligeti
    • 1
  • C. Barlow
    • 1
  • B. Chance
    • 1
  • A. G. B. Kovach
    • 1
  • M. O’Connor
    • 1
  1. 1.Johnson Research Foundation — Expmtl. Res. Lab.University of Penn. — Semmelweis Med. SchoolBudapestHungary

Personalised recommendations